---

(Fierce) - Amarin today tossed another deadline on the bonfire of management vanities, scrapping a self-imposed decision date on hiring a sales force for the recently approved Vascepa. The new deadline is mid-December, when it will get another shot at an FDA decision on new chemical entity status, which has gradually swelled into a major catalyst for the company.

Read more.